INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $244 | – | 1,160 | +1.1% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1,147 | -57.0% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 2,670 | -46.2% | 0.00% | – |
| Q3 2022 | $6,000 | +200.0% | 4,965 | +29.6% | 0.00% | – |
| Q2 2022 | $2,000 | -96.6% | 3,830 | -92.6% | 0.00% | – |
| Q1 2022 | $59,000 | -35.2% | 51,625 | +28.3% | 0.00% | – |
| Q4 2021 | $91,000 | -17.3% | 40,227 | +24.2% | 0.00% | – |
| Q3 2021 | $110,000 | +10.0% | 32,380 | -3.6% | 0.00% | – |
| Q2 2021 | $100,000 | – | 33,606 | +59910.7% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 56 | -99.9% | 0.00% | – |
| Q4 2020 | $88,000 | – | 41,281 | +165024.0% | 0.00% | – |
| Q3 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 25 | +2400.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2019 | $381,000 | -52.7% | 219,055 | -48.9% | 0.00% | – |
| Q1 2019 | $806,000 | +53.5% | 428,589 | -3.7% | 0.00% | – |
| Q4 2018 | $525,000 | +288.9% | 445,185 | +275.9% | 0.00% | – |
| Q3 2017 | $135,000 | -81.5% | 118,435 | -47.6% | 0.00% | – |
| Q1 2017 | $730,000 | +136.2% | 226,101 | -1.3% | 0.00% | – |
| Q4 2016 | $309,000 | -15.3% | 229,145 | -2.0% | 0.00% | – |
| Q3 2016 | $365,000 | -40.6% | 233,900 | -49.4% | 0.00% | – |
| Q2 2016 | $614,000 | -76.3% | 462,200 | -6.1% | 0.00% | -100.0% |
| Q1 2016 | $2,593,000 | -34.1% | 492,050 | -1.8% | 0.00% | 0.0% |
| Q4 2015 | $3,934,000 | -18.6% | 501,125 | -12.4% | 0.00% | 0.0% |
| Q3 2015 | $4,835,000 | -22.5% | 572,175 | +0.4% | 0.00% | 0.0% |
| Q2 2015 | $6,240,000 | +1.5% | 569,932 | +29.6% | 0.00% | 0.0% |
| Q1 2015 | $6,146,000 | +156.4% | 439,702 | +209.9% | 0.00% | 0.0% |
| Q4 2014 | $2,397,000 | +13.3% | 141,903 | -20.2% | 0.00% | 0.0% |
| Q1 2014 | $2,115,000 | -3.6% | 177,848 | +12.0% | 0.00% | 0.0% |
| Q4 2013 | $2,193,000 | -29.1% | 158,801 | -10.6% | 0.00% | 0.0% |
| Q3 2013 | $3,095,000 | -4.4% | 177,589 | -11.1% | 0.00% | 0.0% |
| Q2 2013 | $3,236,000 | – | 199,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |